Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Amorfix Life Science (ARFXF)

Amorfix Life Science (ARFXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN” Globe Newswire - Fri Jul 8, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 08, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN) (“ProMIS” or the...

ARFXF : 0.1020 (-0.58%)
PMN : 1.9600 (-1.26%)
PMN.TO : 6.00 (-3.85%)
PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA Globe Newswire - Mon Jun 27, 2022

TORONTO, Ontario and CAMBRIDGE, MA, June 27, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA Globe Newswire - Mon Jun 27, 2022

TORONTO, Ontario and CAMBRIDGE, MA, June 27, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application Globe Newswire - Wed Jun 22, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts , June 22, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares Globe Newswire - Wed Jun 22, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts, June 22, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
CORRECTION: ProMIS Neurosciences Announces First Quarter 2022 Results Globe Newswire - Fri May 13, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- There was an error at the end of the first paragraph. March 31, 2021 has...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Holds Annual and Special Meeting of Shareholders All Resolutions Approved Globe Newswire - Fri May 13, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces First Quarter 2022 Results Globe Newswire - Fri May 13, 2022

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS) Globe Newswire - Thu Apr 28, 2022

TORONTO, Ontario and CAMBRIDGE, MA, April 28, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS appoints experienced industry veteran Larry Altstiel as Chief Medical Officer Globe Newswire - Tue Apr 19, 2022

Brings decades of experience in Alzheimer’s research at large pharma and biotech...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)

Barchart Exclusives

1 Growth Stock to Scoop Up While It's Cheap Barchart - Fri May 3, 2:17PM CDT
Following its pullback from 52-week highs, this growth stock could be a solid bargain investment now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot